Blood test trial aims to predict uterine Cancer's return
NCT ID NCT05049538
Summary
This study is testing whether simple blood tests, called liquid biopsies, can predict if endometrial (uterine) cancer will come back after treatment. Researchers will collect blood samples from 1,000 women with endometrial cancer at different points during their treatment to track changes in tumor DNA. The goal is to see if these blood tests can serve as a less invasive way to monitor cancer compared to tissue biopsies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CLEAR CELL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.